Biotech

All Articles

Cassava pays $40M over purportedly confusing Alzheimer's update

.Cassava Sciences has accepted pay out $40 million to address an inspection into insurance claims it...

Merck bags possibilities on Evaxion's AI-designed injection candidates

.Merck &amp Co. has picked up choices on 2 Evaxion Biotech vaccine applicants, paying $3.2 thousand ...

Enanta's RSV antiviral crushes viral tons in challenge research study

.Enanta Pharmaceuticals has actually linked its own respiratory syncytial virus (RSV) antiviral to s...

Biogen cans SAGE-324 collaboration after vital trembling fall short

.Biogen has actually conducted the final ceremonies to its partnership along with Sage Rehabs on SAG...

AbbVie Parkinson's drug from $8.7 B Cerevel acquistion ratings

.On the exact same time that some Parkinson's disease medicines are actually being actually called i...

Arch closes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund from Bain Funds Lifestyle Sciences, Arch Venture Partners is actu...

Orion to make use of Aitia's 'electronic doubles' to discover brand-new cancer drugs

.Finnish biotech Orion has snooped prospective in Aitia's "electronic twin" specialist to develop ne...

Windtree's shock med brings up blood pressure in most up-to-date phase 2 gain

.While Windtree Rehabs has actually strained to increase the financial roots needed to have to make ...

2 cancer biotechs combine, making worldwide impact

.OncoC4 is taking AcroImmune-- and also its own in-house professional production capabilities-- unde...

Amgen reports first period 3 gain for $400M chronic eczema drug

.Amgen has discussed (PDF) the first phase 3 records on its own $400 million dermatitis drug, linkin...